Dexcom EVP Sells $226K in Company Stock Under Pre-Arranged Plan
DEXCOM INC
Subscribe to track DXCM
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Dexcom (DXCM) Insider Transaction Insider: Sadie Stern (EVP Chief People & Culture Off) Action: Sale Shares: 2,565 at $88.37/share Total Value: $226,668.45 Date: 2026-08-27 Remaining Shares: 126,043 This transaction was executed under a Rule 10b5-1 trading plan adopted on May 28, 2026.
Comprehensive Analysis
On August 27, 2026, Sadie Stern, the Executive Vice President and Chief People & Culture Officer of Dexcom, sold 2,565 shares of common stock at a price of $88.37 per share, for a total transaction value of approximately $226,668. Following this sale, Ms. Stern directly owns 126,043 shares of Dexcom. This transaction was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted on May 28, 2026. Such plans allow insiders to establish pre-arranged plans to sell company stock, providing an affirmative defense against accusations of trading on non-public information. The remaining shares include 71,903 unvested restricted stock units (RSUs) with various vesting schedules extending to 2029.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.